Journals / Turkish Journal of Pediatrics / 2020 / Cilt: 62 - Sayı: 5

The incidence and clinical effects of Bordetella pertussis in children hospitalized with acute bronchiolitis

Pages
726–733
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Early identification of this pathogen is important in terms of quarantining the patient, administering appropriate antimicrobial treatment, and prophylactic treatment to household and other close contacts.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pertussis is a disease leading to high morbidity and mortality in neonates and infants.
📊
Key Findings & Data:Bronchiolitis is the most common cause of hospitalization especially in children <2 year-old.
💡
Conclusion & Impact:Early identification of this pathogen is important in terms of quarantining the patient, administering appropriate antimicrobial treatment, and prophylactic treatment to household and other close contacts.
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Özet

Background. Pertussis is a disease leading to high morbidity and mortality in neonates and infants. Bronchiolitis is the most common cause of hospitalization especially in children <2 year-old. Although the clinical findings are different in these two diseases, it is sometimes difficult to make this distinction in partially or fully vaccinated children. This study aimed to identify the incidence, clinical and laboratory effects of B. pertussis as a causative agent in hospitalized children with acute bronchiolitis.Methods. The study included patients diagnosed with acute bronchiolitis and admitted to the Division of Pediatric Infectious Diseases from January 2012 to December 2015, aged 24 months or younger, evaluated for viruses and bacteria with polymerase chain reaction in respiratory tract secretions. Results. The study included 380 patients hospitalized with acute bronchiolitis. Of these patients, 85.8% were identified to be positive for at least one respiratory pathogen. The most commonly identified pathogens were respiratory syncytial virus (RSV) A/B, rhinovirus, parainfluenza virus, adenovirus, bocavirus and metapneumovirus A/B. B. pertussis was only detected in 5 patients (1.5%). In the patients with B. pertussisidentified, coinfection with another virus was observed including rhinovirus (n= 2), influenza A virus (n= 1), coronavirus OC43 (n= 1) and RSV A/B (n= 1). The presence of B. pertussis did not appear to cause any significant clinical or laboratory differences in patients.Conclusions. B. pertussis is a rare pathogen in patients admitted to hospital for acute bronchiolitis. However, in patients who do not respond to standard bronchiolitis treatment, B. pertussis should be considered as a causative agent. Early identification of this pathogen is important in terms of quarantining the patient, administering appropriate antimicrobial treatment, and prophylactic treatment to household and other close contacts.

🔖

Cite This Article

EFENDIYEVA, E., KARA, T. T., ERAT, T., YAHŞİ, A., KARBUZ, A., KOCABAŞ, B. A., ÖZDEMİR, H., KARAHAN, Z. C., İNCE, E., ÇİFTÇİ, E. (2020). The incidence and clinical effects of Bordetella pertussis in children hospitalized with acute bronchiolitis. Turkish Journal of Pediatrics, Cilt: 62 - Sayı: 5, 726–733. https://ajindex.com/articles/411872

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Bonhoeffer J, Bär G, Riffelmann M, Solèr M, Heininger U. The role of Bordetella infections in patients with acute exacerbation of chronic bronchitis. Infection 2005; 33: 13-17. 2.Piedimonte G, Perez MK. Respiratory syncytial virus infection and bronchiolitis. Pediatr Rev 2014; 35: 519-530. 3.Roggeri DP, Roggeri A, Rossi E, Cataudella S, Martini N. Impact of hospitalizations for bronchiolitis in preterm infants on long-term health care costs in Italy: a retrospective case-control study. Clinicoecon Outcomes Res 2016; 8: 407-412. 4.Piedra PA, Mansbach JM, Jewell AM, et al. Bordetella pertussis is an uncommon pathogen in children hospitalized with bronchiolitis during the winter season. Pediatr Infect Dis J 2015; 34: 566-570. 5.Korppi M, Kivistö J, Koponen P, et al. Absence of Bordetella pertussis among infants hospitalized for bronchiolitis in Finland, 2008-2010. Pediatr Infect Dis J 2016; 35: 219-221. 6.Abu Raya B, Bamberger E, Kassis I, Kugelman A, Srugo I, Miron D. Bordetella pertussis infection attenuates clinical course of acute bronchiolitis. Pediatr Infect Dis J 2013; 32: 619-621. 7.Siberry GK, Paquette NR, Ross TL, Perl TM, Valsamakis A. Low prevalence of pertussis among children admitted with respiratory symptoms during respiratory syncytial virus season. Infect Control Hosp Epidemiol 2006; 27: 95-97. 8.Gökçe S, Kurugöl Z, Aydemir SŞ, Çiçek C, Aslan A, Koturoğlu G. Bordetella pertussis infection in hospitalized infants with acute bronchiolitis. Indian J Pediatr 2018; 85: 189-193. 9.Nuolivirta K, Koponen P, He Q, et al. Bordetella pertussis infection is common in nonvaccinated infants admitted for bronchiolitis. Pediatr Infect Dis J 2010; 29: 1013-1015. 10.Worrall G. Bronchiolitis. Can Fam Physician 2008; 54: 742-743. 11.Davison C, Ventre KM, Luchetti M, Randolph AG. Efficacy of interventions for bronchiolitis in critically ill infants: a systematic review and meta-analysis. Pediatr Crit Care Med 2004; 5: 482-489. 12.Walsh P, Overmeyer C, Kimmel L, et al. Prevalence of Bordetella pertussis and Bordetella parapertussis in samples submitted for RSV screening. West J Emerg Med 2008; 9: 135-140. 13.Korppi M, Hiltunen J. Pertussis is common in nonvaccinated infants hospitalized for respiratory syncytial virus infection. Pediatr Infect Dis J 2007; 26: 316-318. 14.Miron D, Srugo I, Kra-Oz Z, et al. Sole pathogen in acute bronchiolitis: is there a role for other organisms apart from respiratory syncytial virus? Pediatr Infect Dis J 2010; 29: e7-e10. 15.Wal